Early Detection of Myeloid-Derived Suppressor Cells in the Lung Pre-Metastatic Niche by Shortwave Infrared Nanoprobes

Metastatic breast cancer remains a significant source of mortality amongst breast cancer patients and is generally considered incurable in part due to the difficulty in detection of early micro-metastases. The pre-metastatic niche (PMN) is a tissue microenvironment that has undergone changes to support the colonization and growth of circulating tumor cells, a key component of which is the myeloid-derived suppressor cell (MDSC). Therefore, the MDSC has been identified as a potential biomarker for PMN formation, the detection of which would enable clinicians to proactively treat metastases. However, there is currently no technology capable of the in situ detection of MDSCs available in the clinic. Here, we propose the use of shortwave infrared-emitting nanoprobes for the tracking of MDSCs and identification of the PMN. Our rare-earth albumin nanocomposites (ReANCs) are engineered to bind the Gr-1 surface marker of murine MDSCs. When delivered intravenously in murine models of breast cancer with high rates of metastasis, the targeted ReANCs demonstrated an increase in localization to the lungs in comparison to control ReANCs. However, no difference was seen in the model with slower rates of metastasis. This highlights the potential utility of MDSC-targeted nanoprobes to assess PMN development and prognosticate disease progression.

Defect Engineering of Low-Coordinated Metal-Organic Frameworks (MOFs) for Improved CO2 Access and Capture

While metal-organic frameworks (MOFs) are promising gas adsorbents, their tortuous microporous structures cause additional resistance for gas diffusion, thus hindering the accessibility of interior active sites. Here, we present a practical strategy to incorporate missing cluster defects into a representative low-coordinated MOFs structure, Mg-MOF-74, while maintaining the stability of a defect-rich structure. In this proposed method, graphene oxide (GO) is employed as modulator, and crystallization time is varied to promote defect formation by altering the nucleation and crystal growth processes. The best performing GO-modified Mg-MOF-74 sample (MOF@GO 40 h) achieved 18% and 15% improvement in surface area and total pore volume, respectively, over pristine Mg-MOF-74. The reduced diffusion resistance to gas flow translates to increased accessibility for gas molecules to active Mg adsorption sites inside the MOFs, leading to enhanced CO₂ capture performance; the CO₂ uptake quantity of MOF@GO 40 h arrives at 6.06 mmol/g at 0.1 bar and at 9.17 mmol/g at 1 bar and 25 °C, 19.29% and 16.37% higher, respectively, than that of the pristine Mg-MOF-74, with a CO₂/N₂ selectivity around 17.36% greater than that of pristine Mg-MOF-74. Our study demonstrates a facile approach for incorporating defects into MOFs systems with low coordination environments, thus expanding the library of defect-rich MOFs beyond the current highly coordinated MOF systems.

Short-Wave Infrared Emitting Nanocomposites for Fluorescence-Guided Surgery

Fluorescence-guided surgery (FGS) is an emerging technique for tissue visualization during surgical procedures. Structures of interest are labeled with exogenous probes whose fluorescent emissions are acquired and viewed in real-time with optical imaging systems. This study investigated rare-earth-doped albumin-encapsulated nanocomposites (REANCs) as short-wave infrared emitting contrast agents for FGS. Experiments were conducted using an animal model of 4T1 breast cancer. The signal-to-background ratio (SBR) obtained with REANCs was compared to values obtained using indocyanine green (ICG), a near-infrared dye used in clinical practice. Prior to resection, the SBR for tumors following intratumoral administration of REANCs was significantly higher than for tumors injected with ICG. Following FGS, evaluation of fluorescence intensity levels in excised tumors and at the surgical bed demonstrated higher contrast between tissues at these sites with REANC contrast than ICG. REANCs also demonstrated excellent photostability over 2 hours of continuous illumination, as well as the ability to perform FGS under ambient lighting, establishing these nanocomposites as a promising contrast agent for FGS applications.

Abstract 2802: Rare earth albumin nanoparticles engineered to target cytotoxic T cells to evaluate response to immunotherapy

Checkpoint immunotherapy, through the reversal of tumor-mediated inactivation of the immune system, has shown promise in the treatment of several types of cancer. This has culminated in the approval of seven immune checkpoint inhibitors (ICIs). However, only a small population of patients respond to these drugs. Because of the physical and economic burden of ICIs on the patient, there is a critical need to identify biomarkers that can inform on the potential response to ICIs. The presence of tumor infiltrating lymphocytes (TILs) has demonstrated good prognostic value in determining if a patient should receive ICIs. Current clinical methods to assess TILs involve invasive biopsies and immunohistochemistry, which suffer from intratumoral heterogeneity, observer variability, and a lack of real-time feedback. Here, we report on near infrared light excitable rare earth metal-based nanoparticles, termed rare earth albumin nanocomposites (ReANCs), that emit shortwave infrared (SWIR) light, allowing for deep tissue imaging and high signal-to-noise ratios compared to visible or near infrared fluorescence probes. Tumor-targeted ReANCs have been previously employed to monitor tumor progression and response to chemotherapy in mouse models of breast cancer metastasis. In this study, to target CD3+ T cells, ReANCs were conjugated using the zero-length cross-linker 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) to a peptide derived from the sequence of the CD3-ϵ receptor sub-unit. Target specific binding was validated by flow cytometry as a measure of increased uptake of peptide-conjugated ReANCs by Jurkat cells. To specifically target cytotoxic T lymphocytes, we employed the fragment antigen binding (Fab) derived from enzymatic digestion of a CD8 antibody (clone 53-6.7) with papain. The Fab fragments were conjugated to ReANCs with sulfo-succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (sulfo-SMCC). Conjugation was confirmed by non-reducing gel electrophoresis and high performance liquid chromatography (HPLC). A loading efficiency of approximately 60% was achieved. Target specific binding was validated by flow cytometry as a measure of increased uptake of Fab-conjugated ReANCs by T cells isolated from splenocytes. We generated a metric for measuring immune burden around tumor spheroids by pre-labeling T cells with ReANCs and co-culturing them with tumor cell spheroids in vitro. Imaging of T cells with CD3 and CD8-targeted ReANCs provides a basis for future in vivo small animal imaging studies where we will investigate the potential of this technology to track immune cells in relation to a tumor in real time. Metrics of immune cell imaging will then inform on the potential of immunotherapy and monitor response to treatment in a longitudinal study.

Citation Format: Jay V. Shah, Jake N. Siebert, Amber Gonda, Rahul Pemmaraju, Shashank Kosuri, Carolina Bobadilla Mendez, Xinyu Zhao, Shuqing He, Richard E. Riman, Mei Chee Tan, Mark C. Pierce, Edmund C. Lattime, Prabhas V. Moghe, Vidya Ganapathy. Rare earth albumin nanoparticles engineered to target cytotoxic T cells to evaluate response to immunotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2802.

Synthesis of deep red emitting Cu-In-Zn-Se/ZnSe quantum dots for dual-modal fluorescence and photoacoustic imaging

CuInSe₂ quantum dots (QDs) are one of the most important Cd-free fluorescent probes; they usually exhibited low fluorescence intensity, suggesting that a considerable amount of absorbed photon energy was lost as heat. In this study we aimed to improve the fluorescence intensity of CuInSe₂ QDs and investigate their photoacoustic (PA) signal resulting from the heat dissipation, which was previously rarely reported. Cu-In-Zn-Se/ZnSe QDs were synthesized by adopting two strategies of Zn doping and ZnSe shell growth. It was found that there was an upper limit for Zn concentration beyond which the fluorescence intensity began to decrease. In addition, a blue shift of the emission peak of Cu-In-Zn-Se/ZnSe QDs was observed at high concentrations of ZnSe precursor due to the diffusion of excessive Zn. To prepare the dual-modal fluorescence and PA imaging probe, poly(maleic anhydride-alt-1-octadecene) (PMAO) modified with polyethylene glycol (PEG) was coated on the QDs, which led to a slight reduction in fluorescence. Cellular labeling on HeLa cells was performed to demonstrate the utility of these probes for fluorescence imaging. We further studied the in vitro PA imaging capabilities of the Cu-In-Zn-Se/ZnSe/PMAO-g-PEG nanoparticles, which showed a distinct PA signal beyond 1.0 mg ml^-1. The current work demonstrated that a moderate amount of Zn doping is necessary for enhancing fluorescence and there is a limit beyond which the fluorescence will be diminished. We also demonstrated the proof of concept that Cu-In-Zn-Se/ZnSe QDs are able to serve as a potential PA imaging contrast agent.

Shortwave infrared emitting multicolored nanoprobes for biomarker-specific cancer imaging in vivo

BACKGROUND

The ability to detect tumor-specific biomarkers in real-time using optical imaging plays a critical role in preclinical studies aimed at evaluating drug safety and treatment response. In this study, we engineered an imaging platform capable of targeting different tumor biomarkers using a multi-colored library of nanoprobes. These probes contain rare-earth elements that emit light in the short-wave infrared (SWIR) wavelength region (900-1700 nm), which exhibits reduced absorption and scattering compared to visible and NIR, and are rendered biocompatible by encapsulation in human serum albumin. The spectrally distinct emissions of the holmium (Ho), erbium (Er), and thulium (Tm) cations that constitute the cores of these nanoprobes make them attractive candidates for optical molecular imaging of multiple disease biomarkers.

METHODS

SWIR-emitting rare-earth-doped albumin nanocomposites (ReANCs) were synthesized using controlled coacervation, with visible light-emitting fluorophores additionally incorporated during the crosslinking phase for validation purposes. Specifically, HoANCs, ErANCs, and TmANCs were co-labeled with rhodamine-B, FITC, and Alexa Fluor 647 dyes respectively. These Rh-HoANCs, FITC-ErANCs, and 647-TmANCs were further conjugated with the targeting ligands daidzein, AMD3100, and folic acid respectively. Binding specificities of each nanoprobe to distinct cellular subsets were established by in vitro uptake studies. Quantitative whole-body SWIR imaging of subcutaneous tumor bearing mice was used to validate the in vivo targeting ability of these nanoprobes.

RESULTS

Each of the three ligand-functionalized nanoprobes showed significantly higher uptake in the targeted cell line compared to untargeted probes. Increased accumulation of tumor-specific nanoprobes was also measured relative to untargeted probes in subcutaneous tumor models of breast (4175 and MCF-7) and ovarian cancer (SKOV3). Preferential accumulation of tumor-specific nanoprobes was also observed in tumors overexpressing targeted biomarkers in mice bearing molecularly-distinct bilateral subcutaneous tumors, as evidenced by significantly higher signal intensities on SWIR imaging.

CONCLUSIONS

The results from this study show that tumors can be detected in vivo using a set of targeted multispectral SWIR-emitting nanoprobes. Significantly, these nanoprobes enabled imaging of biomarkers in mice bearing bilateral tumors with distinct molecular phenotypes. The findings from this study provide a foundation for optical molecular imaging of heterogeneous tumors and for studying the response of these complex lesions to targeted therapy.

Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring

Therapeutic drug monitoring (TDM) in cancer, while imperative, has been challenging due to inter-patient variability in drug pharmacokinetics. Additionally, most pharmacokinetic monitoring is done by assessments of the drugs in plasma, which is not an accurate gauge for drug concentrations in target tumor tissue. There exists a critical need for therapy monitoring tools that can provide real-time feedback on drug efficacy at target site to enable alteration in treatment regimens early during cancer therapy. Here, we report on theranostic optical imaging probes based on shortwave infrared (SWIR)-emitting rare earth-doped nanoparticles encapsulated with human serum albumin (abbreviated as ReANCs) that have demonstrated superior surveillance capability for detecting micro-lesions at depths of 1 cm in a mouse model of breast cancer metastasis. Most notably, ReANCs previously deployed for detection of multi-organ metastases resolved bone lesions earlier than contrast-enhanced magnetic resonance imaging (MRI). We engineered tumor-targeted ReANCs carrying a therapeutic payload as a potential theranostic for evaluating drug efficacy at the tumor site. In vitro results demonstrated efficacy of ReANCs carrying doxorubicin (Dox), providing sustained release of Dox while maintaining cytotoxic effects comparable to free Dox. Significantly, in a murine model of breast cancer lung metastasis, we demonstrated the ability for therapy monitoring based on measurements of SWIR fluorescence from tumor-targeted ReANCs. These findings correlated with a reduction in lung metastatic burden as quantified via MRI-based volumetric analysis over the course of four weeks. Future studies will address the potential of this novel class of theranostics as a preclinical pharmacological screening tool.

Biodegradable rare earth fluorochloride nanocrystals for phototheranostics

Rare earth (RE) doped inorganic nanocrystals have been demonstrated as efficient contrast agents for deep tissue shortwave-infrared (SWIR) imaging with high sensitivities leading to potential early detection of tumors. However, a potential concern is the unknown long-term toxicity and incompatibility of inorganic nanocrystals. In this work, biodegradable rare earth nanocrystals of Nd doped SrFCl coated with polydopamine (SrFCl:Nd@PDA) were designed. Instead of traditional fluoride hosts, the chlorinated SrF₂ (i.e. SrFCl) with low phonon energy which significantly improved the brightness of SrFCl:Nd in the SWIR region was used as the host. After coating with a NIR-absorptive PDA layer, the SrFCl:Nd nanoparticles serve as not only a contrast agent for photoacoustic imaging, but also a potential photothermal agent for cancer therapy. Moreover, these SrFCl:Nd@PDA nanoparticles can be rapidly and completely degraded in phosphate buffer solution within 1 h, which effectively addresses the concerns of the deleterious effects arising from potential long term accumulation. The increased accumulation and retention at tumor sites, and complete in vivo clearance ∼6 h after injection make these SrFCl:Nd@PDA nanoparticles a promising degradable phototheranostic agent.

Engineering the Infrared Luminescence and Photothermal Properties of Double-Shelled Rare-Earth-Doped Nanoparticles for Biomedical Applications

The nascent field of theranostics, which couples targeted therapy with diagnostics, has catalyzed efforts toward improved nanoprobe designs that facilitate both localized treatment and diagnostic imaging. Rare-earth-doped nanoparticles (RENPs) have emerged as a leading candidate for theranostics because of their versatile synthesis and modification chemistries, photostability, and relative safety. Furthermore, their bright, tunable fluorescence using near-infrared (NIR) excitation enables multispectral imaging with high signal-to-background ratios. In this work, we have synthesized double-shelled RENPs with tunable properties for optimal fluorescent imaging, photoacoustic imaging, and photothermal therapy. The properties of the double-shelled RENPs were tailored by controlling the density of rare-earth ions (i.e., activator or sensitizer) by using either a functional amorphous organic or a crystalline outermost shell. This study systematically analyzes the effects of the functional organic or inorganic outermost shell on the imaging and photothermal conversion properties of our RENPs. Despite the weaker infrared absorption enhancement, the functional organic outermost shell impregnated with a low density of rare-earth ions led to minimal reduction of fluorescence emissions. In contrast, the higher density of rare-earth ions in the inorganic shell led to higher infrared absorption and consequently significant reduction in emissions arising from the undesired optical attenuation. Inorganic shell thickness was therefore modified to reduce the deleterious attenuation, leading to brighter emissions that also enabled the in vitro SWIR detection of ∼2500 cells/cluster. Using the enhanced infrared properties that arise from this functional inorganic layer, which could be engineered to respond to either NIR or SWIR, we demonstrated that (1) bright SWIR emissions allowed detection of small cell clusters; (2) strong PA signals allowed clear visualization of particle distribution within tumors; and (3) strong photothermal effects resulted in localized elevated temperatures. Collectively, these results highlight the utility of these double-shelled RENPs as theranostic agents that are compatible with both photoacoustic or fluorescent imaging platforms.

High-Performance and Flexible Shortwave Infrared Photodetectors Using Composites of Rare Earth-Doped Nanoparticles

The growing demand of infrared sensors for emerging applications such as autonomous vehicles and remote control and sensing systems has driven the development of flexible, low-power, and sensitive infrared detectors for seamless product integration. Although semiconducting polymer (SCP)-based photodetectors are promising solutions, challenges in synthesis chemistry and high thermal dark currents associated with narrowing of band gaps have limited their progress. To address these challenges, we have designed a new class of composites comprising SCPs with moderate band gap and rare earth doped-nanoparticles (RENPs) that enable photon-to-electron conversion beyond the SCP's response range. Using this RENP-SCP (RE-SCP) composite, we demonstrated detection at multiple wavelengths (808, 975, and 1532 nm) for planar-type photodetectors. Notably, the RE-SCP composite-based device detected an eye-safe, shortwave infrared (SWIR) source at 1532 nm with high SWIR responsivity of 0.02 A/W and an SWIR external quantum efficiency of 2%. The key attribute governing the excellent SWIR responsivity and sensitivity was the distinctive SWIR upconversion characteristic of RENPs that extended and improved the SCP's detection range and performance, respectively. Additionally, the absence of significant performance degradation of the SWIR photodetector for bending curvatures from 0-0.67 cm^-1 highlights the promise of our RE-SCP composite-based flexible SWIR photodetectors.

Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans

BACKGROUND

Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) may reduce the risk of oesophageal adenocarcinoma (OAC) in Barrett's oesophagus; however, current epidemiologic studies are inconclusive.

AIM

To evaluate the independent effects of PPIs and H2RAs on risk of OAC in patients with Barrett's oesophagus.

METHODS

We conducted a nested case-control study of male veterans diagnosed with Barrett's oesophagus. Cases with incident OAC were matched by incidence density sampling on birth year and Barrett's diagnosis date to controls with Barrett's oesophagus who did not develop OAC. We identified prescription medication usage 1 year prior to Barrett's oesophagus diagnosis to 3 months prior to the OAC diagnosis. Odds ratios (OR) and 95% CI were estimated using conditional logistic regression.

RESULTS

Compared with 798 controls, the 300 cases were less likely to use PPIs (90.0% vs 94.5%, P = 0.01) and H2RAs (19.7% vs 25.7%, P = 0.04). In the multivariable model including the use of statins, H2RAs, aspirin and nonsteroidal anti-inflammatory drugs, PPI use was associated with 41% lower risk of OAC (OR 0.59, 95% CI 0.35-0.99). While risk reduction of OAC was stronger for high-dose PPIs (omeprazole daily dose >40 mg, adjusted OR 0.11, 95% 0.04-0.36), we did not find a dose-response relationship with PPI duration (P trend = 0.45). Likewise, H2RA use was independently associated with 30% lower risk of OAC (OR 0.70, 95% CI 0.50-0.99).

CONCLUSION

Use of PPIs and H2RAs among patients with Barrett's oesophagus are associated with lower risk of OAC. Further clinical trials are needed to confirm this possible chemopreventive effect.

Surface-Modified Shortwave-Infrared-Emitting Nanophotonic Reporters for Gene-Therapy Applications

Gene therapy is emerging as the next generation of therapeutic modality with United States Food and Drug Administration approved gene-engineered therapy for cancer and a rare eye-related disorder, but the challenge of real-time monitoring of on-target therapy response remains. In this study, we have designed a theranostic nanoparticle composed of shortwave-infrared-emitting rare-earth-doped nanoparticles (RENPs) capable of delivering genetic cargo and of real-time response monitoring. We showed that the cationic coating of RENPs with branched polyethylenimine (PEI) does not have a significant impact on cellular toxicity, which can be further reduced by selectively modifying the surface characteristics of the PEI coating using counter-ions and expanding their potential applications in photothermal therapy. We showed the tolerability and clearance of a bolus dose of RENPs@PEI in mice up to 7 days after particle injection in addition to the RENPs@PEI ability to distinctively discern lung tumor lesions in a breast cancer mouse model with an excellent signal-to-noise ratio. We also showed the availability of amine functional groups in the collapsed PEI chain conformation on RENPs, which facilitates the loading of genetic cargo that hybridizes with target gene in an in vitro cancer model. The real-time monitoring and delivery of gene therapy at on-target sites will enable the success of an increased number of gene- and cell-therapy products in clinical trials.

Abstract 4119: Spatial mapping and molecular phenotyping of heterogeneous breast cancer lesions with multi-spectral short wave infrared emitting rare-earth nanoprobes

Breast cancer is made up of distinct heterogeneous subpopulations that influence treatment responses. Currently, molecular phenotyping of a tumor involves post-biopsy histology, which makes quantification and assessment of spatial heterogeneity difficult. While there has been moderate success in radiographic imaging of heterogeneity, by PET and MRI, there is an urgent need for non-invasive imaging modalities to quantitatively index tumor heterogeneity in real-time. Our study utilizes rare earth(Re) nanoprobes which absorb near infrared radiation (980nm) and emit in the short wave infrared (SWIR) region (1000- 3000nm), allowing for improved tissue penetration and detection depth. We designed Re nanoprobes encapsulated in albumin to form Rare-Earth Albumin NanoComposites (ReANCs), which can be administered in vivo to target and detect deep tissue microlesions (~18mm3) at a depth of ~1cm. Additionally, ReANCs have been shown to detect multi-organ micro-lesions early and have excellent safety and tolerability profile. Albumin encapsulation not only creates a biocompatible nanoparticle, but also allows for increased biodistribution, pharmacokinetics, and the possibility of functionalization. Most notably, the availability of different Re dopants, Erbium and Thulium, with distinct emission spectral bands allows for accurate indexing of cellular subsets. In this study, we first demonstrate the ability of multi-spectral, ReANCs to distinguish and map a heterogeneous tumor lesion. 3D spheroids made of varying ratios of prelabeled populations of MDA-MB-231 cells (erbium-doped) and HCC1954 (thulium doped) were engineered and imaged to obtain a training set for spatial mapping of the different cell populations. Ratiometric analysis of the spheroids was performed to develop an algorithm for indexing. Subsequently, cancer-targeted ReANCs were engineered and target validation was performed in a 3D spheroid model followed by spatial mapping of targeted populations leading to ratiometric indexing of the different populations. Briefly, erbium doped ReANCs (MDA-MB-231 cells) and thulium doped ReANCs (HCC1954 cells), were deployed to detect distinct subpopulations in a 3D heterogeneous spheroid model of Her2+/- breast cancer. Images were obtained using in vitro microscopy platforms, using 980 nm excitation sources. Separate band-pass filters isolated emissions from the distinct REANC dopants, allowing for quantification of each pre-labeled cell in the training set. This was followed by development of an algorithm to find the percentage of subsets with unknown proportions allowing indexing of unknown subsets in a single tumor spheroid. This novel in vivo imaging modality forms the early basis for real-time on molecular aspects of the tumor and real-time tumor response tracking.

Citation Format: Harini Kantamneni, Michael Donzanti, Xinyu Zhao, Shuqing He, Mei Chee Tan, Mark Pierce, Charles M. Roth, Shridar Ganesan, Vidya Ganapathy, Prabhas V. Moghe. Spatial mapping and molecular phenotyping of heterogeneous breast cancer lesions with multi-spectral short wave infrared emitting rare-earth nanoprobes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4119.

Size and surface effects on chemically-induced joining of Ag conductive inks

The underlying roles of particle size effects and ionic salts are uncovered for optimal chemically-induced sintering as a scalable approach to join metallic nanomaterials to create efficient sensors.

Synthesis of Uniform Rare Earth Doped Gd2O2S Sub-micron Sized Spheres Using Gas-Aided Sulfurization and their Optical Characteristics

In this work, we report a detailed study of the synthesis of sub-micron sized Gd2O2S spheres using a two-step process: (1) amorphous precursor synthesis using the solvothermal method where a surfactant was used to control particle morphology, followed by (2) crystallization to form Gd2O2S polycrystalline spheres in a sulfur-rich environment. The crystallization and sulfurization processes are investigated by monitoring the crystal growth at different temperatures and under different environments using mainly x-ray diffraction and analysis of the precursor's thermal decomposition profile. The optical emissions of the Er and Yb-Er doped Gd2O2S upon excitation at 975 nm were investigated to identify the optimal dopant concentrations, optimal heat treatment temperature as well as to further elucidate any fine structure changes. Our results also show that the maximum emission intensities were obtained for a heat treatment temperature of 800 °C, where increased dopant diffusion coupled with non-uniform surface segregation at much higher temperatures led to non-uniform dopant distribution and reduced emission intensities. Our findings from these studies would be useful towards the synthesis of brightly-emitting Gd2O2S based luminescent materials as well as for the controlled gas-aided sulfurization of other metal oxysulfides.

Advancements in infrared imaging platforms: complementary imaging systems and contrast agents

Recent advancements in the infrared (IR) imaging system design as well as the co-development of compatible contrast agents have facilitated the potential application of fluorescence imaging systems for deep tissue diagnostics and real-time vasculature visualization for intraoperative surgical guidance. Compared to conventional imaging techniques that achieve superior tissue penetration depth through the use of high energy or ionizing radiation sources, complementary chemical compounds, also known as imaging probes or contrast agents, are required to enable enhancement of the imaging sensitivity required for improved image quality in the IR fluorescence imaging technique. Therefore, using a systems-level approach to plan research efforts where the requirements of the imaging setup are considered at the start of the contrast agent design to effectively improve detection sensitivity would reduce the technical entry barrier for the adoption of new technologies. In this paper, we highlight (1) the recent advancements and key operating differences in the reported IR imaging systems, and (2) the recent progress in creating biocompatible IR-emitting contrast agents as well as improving detection sensitivity using targeting agents. The ability to maximize the full benefits and performance of any IR imaging platform is highly reliant on the thorough understanding of the requirements of each imaging platform and the physical characteristics of the complementary contrast agents.

Fabrication and interfacial characteristics of surface modified Ag nanoparticle based conductive composites

Surface modification of Ag nanoparticles with PAA–PVP complex was conducted and successfully improved the dispersion of Ag nanoparticles in PDMS.

Facile Synthesis of Monodisperse Nanostructured Silver Micro-Colloids via Controlled Agglomeration and Coalescence

Silver nanostructures have expansive applications in catalysis, photonic and electronic devices. In this work, nanostructured silver micro-colloids (MCs) with uniform in size and shape (size distribution <5%) were synthesized via rapid reduction of silver nitrate by ascorbic acid with controlled agglomeration and coalescence. We further propose that the formation of silver MCs was controlled by the chemical reaction kinetics which is governed by the concentration of reduced silver, Agº formed in solution. Preliminary electrical measurements of the highly conductive silver MCs demonstrated their potential application as inks for printed electronics.

Tailoring SWIR emission in tri-lanthanide-doped CaF2 nanoparticles

Erbium doped CaF₂ nanophosphors with enhanced short-wavelength infrared emission synthesized in this work have promising potential for deep tissue imaging due to their low vibrational energy and superior biocompatibility.

CXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection

Realizing the promise of precision medicine in cancer therapy depends on identifying and tracking cancerous growths to maximize treatment options and improve patient outcomes. This goal of early detection remains unfulfilled by current clinical imaging techniques that fail to detect lesions due to their small size and suborgan localization. With proper probes, optical imaging techniques can overcome this by identifying the molecular phenotype of tumors at both macroscopic and microscopic scales. In this study, the first use of nanophotonic short wave infrared technology is proposed to molecularly phenotype small lesions for more sensitive detection. Here, human serum albumin encapsulated rare-earth nanoparticles (ReANCs) with ligands for targeted lesion imaging are designed. AMD3100, an antagonist to CXCR4 (a classic marker of cancer metastasis) is adsorbed onto ReANCs to form functionalized ReANCs (fReANCs). fReANCs are able to preferentially accumulate in receptor positive lesions when injected intraperitoneally in a subcutaneous tumor model. fReANCs can also target subtissue microlesions at a maximum depth of 10.5 mm in a lung metastatic model of breast cancer. Internal lesions identified with fReANCs are 2.25 times smaller than those detected with ReANCs. Thus, an integrated nanoprobe detection platform is presented, which allows target-specific identification of subtissue cancerous lesions.

Cost-Effective and Highly Photoresponsive Nanophosphor-P3HT Photoconductive Nanocomposite for Near-Infrared Detection

The advent of flexible optoelectronic devices has accelerated the development of semiconducting polymeric materials. We seek to replace conventional expensive semiconducting photodetector materials with our cost-effective composite system. We demonstrate in this work the successful fabrication of a photoconductive composite film of poly(3-hexylthiophene-2,5-diyl) (P3HT) mixed with NaYF4:Yb,Er nanophosphors that exhibited a ultrahigh photoresponse to infrared radiation. The high photocurrent measured was enabled by the unique upconversion properties of NaYF4:Yb,Er nanophosphors, where low photon energy infrared excitations are converted to high photon energy visible emissions that are later absorbed by P3HT. Here we report, a significant 1.10 × 10(5) times increment of photocurrent from our photoconductive composite film upon infrared light exposure, which indicates high optical-to-electrical conversion efficiency. Our reported work lays the groundwork for the future development of printable, portable flexible and functional photonic composites for light sensing and harvesting, photonic memory devices, and phototransistors.

Line-scanning confocal microscopy for high-resolution imaging of upconverting rare-earth-based contrast agents

Rare-earth (RE) doped nanocomposites emit visible luminescence when illuminated with continuous wave near-infrared light, making them appealing candidates for use as contrast agents in biomedical imaging. However, the emission lifetime of these materials is much longer than the pixel dwell times used in scanning intravital microscopy. To overcome this limitation, we have developed a line-scanning confocal microscope for high-resolution, optically sectioned imaging of samples labeled with RE-based nanomaterials. Instrument performance is quantified using calibrated test objects. NaYF4 : Er,Yb nanocomposites are imaged in vitro, and in ex vivo tissue specimens, with direct comparison to point-scanning confocal microscopy. We demonstrate that the extended pixel dwell time of line-scanning confocal microscopy enables subcellular-level imaging of these nanomaterials while maintaining optical sectioning. The line-scanning approach thus enables microscopic imaging of this emerging class of contrast agents for preclinical studies, with the potential to be adapted for real-time in vivo imaging in the clinic.

Large Area Directed Self-Assembly of Sub-10 nm Particles with Single Particle Positioning Resolution

Directed self-assembly of nanoparticles (DSA-n) holds great potential for device miniaturization in providing patterning resolution and throughput that exceed existing lithographic capabilities. Although nanoparticles excel at assembling into regular close-packed arrays, actual devices on the other hand are often laid out in sparse and complex configurations. Hence, the deterministic positioning of single or few particles at specific positions with low defect density is imperative. Here, we report an approach of DSA-n that satisfies these requirements with less than 1% defect density over micrometer-scale areas and at technologically relevant sub-10 nm dimensions. This technique involves a simple and robust process where a solvent film containing sub-10 nm gold nanoparticles climbs against gravity to coat a prepatterned template. Particles are placed individually into nanoscale cavities, or between nanoposts arranged in varying degrees of geometric complexity. Brownian dynamics simulations suggest a mechanism in which the particles are pushed into the template by a nanomeniscus at the drying front. This process enables particle-based self-assembly to access the sub-10 nm dimension, and for device fabrication to benefit from the wealth of chemically synthesized nanoparticles with unique material properties.

Directed Self-Assembly of sub-10 nm Particles: Role of Driving Forces and Template Geometry in Packing and Ordering

By comparing the magnitude of forces, a directed self-assembly mechanism has been suggested previously in which immersion capillary is the only driving force responsible for packing and ordering of nanoparticles, which occur only after the meniscus recedes. However, this mechanism is insufficient to explain vacancies formed by directed self-assembly at low particle concentrations. Utilizing experiments, and Monte Carlo and Brownian dynamics simulations, we developed a theoretical model based on a new proposed mechanism. In our proposed mechanism, the competing driving forces controlling the packing and ordering of sub-10 nm particles are (1) the repulsive component of the pair potential and (2) the attractive capillary forces, both of which apply at the contact line. The repulsive force arises from the high particle concentration, and the attractive force is caused by the surface tension at the contact line. Our theoretical model also indicates that the major part of packing and ordering of nanoparticles occurs before the meniscus recedes. Furthermore, utilizing our model, we are able to predict the various self-assembly configurations of particles as their size increases. These results lay out the interplay between driving forces during directed self-assembly, motivating a better template design now that we know the importance and the dominating driving forces in each regime of particle size.

Rare Earth Nanoprobes for Functional Biomolecular Imaging and Theranostics

Contrast agents designed to visualize the molecular mechanisms underlying cancer pathogenesis and progression have deepened our understanding of disease complexity and accelerated the development of enhanced drug strategies targeted to specific biochemical pathways. For the next generation probes and imaging systems to be viable, they must exhibit enhanced sensitivity and robust quantitation of morphologic and contrast features, while offering the ability to resolve the disease-specific molecular signatures that may be critical to reconstitute a more comprehensive portrait of pathobiology. This feature article provides an overview on the design and advancements of emerging biomedical optical probes in general and evaluates the promise of rare earth nanoprobes, in particular, for molecular imaging and theranostics. Combined with new breakthroughs in nanoscale probe configurations, and improved dopant compositions, and multimodal infrared optical imaging, rare-earth nanoprobes can be used to address a wide variety of biomedical challenges, including deep tissue imaging, real-time drug delivery tracking and multispectral molecular profiling.

Template-induced structure transition in sub-10 nm self-assembling nanoparticles

We report on the directed self-assembly of sub-10 nm gold nanoparticles confined within a template comprising channels of gradually varying widths. When the colloidal lattice parameter is mismatched with the channel width, the nanoparticles rearrange and break their natural close-packed ordering, transiting through a range of structural configurations according to the constraints imposed by the channel. While much work has been done in assembling ordered configurations, studies of the transition regime between ordered states have been limited to microparticles under applied compression. Here, with coordinated experiments and Monte Carlo simulations we show that particles transit through a more diverse set of self-assembled configurations than observed for compressed systems. The new insight from this work could lead to the control and design of complex self-assembled patterns other than periodic arrays of ordered particles.

Rare-earth-doped biological composites as in vivo shortwave infrared reporters

The extension of in vivo optical imaging for disease screening and image-guided surgical interventions requires brightly-emitting, tissue-specific materials that optically transmit through living tissue and can be imaged with portable systems that display data in real-time. Recent work suggests that a new window across the short wavelength infrared region can improve in vivo imaging sensitivity over near infrared light. Here we report on the first evidence of multispectral, real-time short wavelength infrared imaging offering anatomical resolution using brightly-emitting rare-earth nanomaterials and demonstrate their applicability toward disease-targeted imaging. Inorganic-protein nanocomposites of rare-earth nanomaterials with human serum albumin facilitated systemic biodistribution of the rare-earth nanomaterials resulting in the increased accumulation and retention in tumor tissue that was visualized by the localized enhancement of infrared signal intensity. Our findings lay the groundwork for a new generation of versatile, biomedical nanomaterials that can advance disease monitoring based on a pioneering infrared imaging technique.

Engineering the Design of Brightly-Emitting Luminescent Nanostructured Photonic Composite Systems

Rare-earth doped infrared emitting composites have extensive applications in integrated optical devices such as fibre amplifiers and waveguides for telecommunications, remote sensing, and optoelectronics. In addition, recent advancements in infrared optical imaging systems have expanded the biomedical applications for infrared-emitting composites in diagnosis and imaging of living tissue systems both in vitro and in vivo. Composite systems combine the advantages of polymers (light weight, flexibility, good impact resistance, improved biomedical compatibility, and excellent processability) and inorganic phosphor host materials (low phonon energy, intense emissions, chemical durability, and high thermal stability). This paper provides a brief review of our research progress in the design and synthesis of luminescent photonic nanocomposite systems comprised of rare-earth doped particulates dispersed in a continuous polymeric matrix. The design of brightly-emitting rare-earth doped materials and the influence of host and dopant chemistries on the emission properties are discussed. Methods used to assess and measure the phosphors’ performance are also evaluated in this work. This paper will also examine the solvothermal synthesis method used to control the physical and chemical characteristics of the rare-earth doped particles, and how these characteristics impact the infrared optical properties. Also presented here are recent advances reported with luminescent nanocomposite systems fabricated for optical waveguides and biomedical imaging.

Surfactant effects on efficiency enhancement of infrared-to-visible upconversion emissions of NaYF4:Yb-Er

Infrared-to-visible rare earth doped upconversion phosphors that convert multiple photons of lower energy to higher energy photons offer a wide range of technological applications. The brightness (i.e., emission intensities) and energy efficiency of phosphors are important performance characteristics that determine which applications are appropriate. Optical efficiency can be used as a measure of the upconversion emission performance of these rare earth doped phosphors. In this work, hexagonal-phase NaYF(4):Yb-Er was synthesized using the hydrothermal method in the presence of surfactants like trioctylphosphine, polyethylene glycol monooleate, and polyvinylpyrrolidone. The upconversion emission optical efficiencies of NaYF(4):Yb-Er were measured to quantify and evaluate the effects of surface coatings and accurately reflect the brightness and energy efficiency of these phosphors. Polyvinylpyrrolidone-modified NaYF(4):Yb-Er particles were found to be ~5 times more efficient and brighter than the unmodified particles. The difference in efficiency was attributed to reduced reflectance losses at the particle-air interface via refractive index mismatch reduction between the core NaYF(4):Yb-Er particles and air using polyvinylpyrrolidone as a surfactant.

Transparent infrared-emitting CeF3:Yb-Er polymer nanocomposites for optical applications

Bright infrared-emitting nanocomposites of unmodified CeF(3):Yb-Er with polymethyl-methacrylate (PMMA) and polystyrene (PS), which offer a vast range of potential applications, which include optical amplifiers, waveguides, laser materials, and implantable medical devices, were developed. For the optical application of these nanocomposites, it is critical to obtain highly transparent composites to minimize absorption and scattering losses. Preparation of transparent composites typically requires powder processing approaches that include sophisticated particle size control, deagglomeration, and dispersion stabilization methods leading to an increase in process complexity and processing steps. This work seeks to prepare transparent composites with high solids loading (>5 vol%) by matching the refractive index of the inorganic particle with low cost polymers like PMMA and PS, so as to circumvent the use of any complex processing techniques or particle surface modification. PS nanocomposites were found to exhibit better transparency than the PMMA nanocomposites, especially at high solids loading (>/=10 vol%). It was found that the optical transparency of PMMA nanocomposites was more significantly affected by the increase in solids loading and inorganic particle size because of the larger refractive index mismatch of the PMMA nanocomposites compared to that of PS nanocomposites. Rayleigh scattering theory was used to provide a theoretical estimate of the scattering losses in these ceramic-polymer nanocomposites.

A solvothermal route to size- and phase-controlled highly luminescent NaYF4:Yb,Er up-conversion nanocrystals

Size-controlled hexagonal- and cubic-phase NaYF4:Yb,Er nanocrystals with bright fluorescent emission were successfully synthesized via a solvothermal approach at a relatively low temperature (< 300 degrees C). A mixture of ethanol and ethylene glycol or pure ethylene glycol was used as a solvent, whereby changing the ethanol concentration. It is found that, besides reaction temperature and time, the reactant concentration is an important factor to control crystal phase. High reactant concentration, high reaction temperature, high concentration of ethanol and long reaction durations are favorable to the formation of brightly emitting hexagonal-phase nanocrystals. The effects of these reaction conditions on the size and the luminescent properties of the as-prepared nanocrystals are discussed. It is found that 30-120 nm hexagonal NaYF4:Yb,Er nanoparticles can be prepared using 0.04 M reactant concentration in 0-60% ethanol solution at 220 degrees C for 24 h.

Interfacial properties and in vitro cytotoxic effects of surface-modified near infrared absorbing Au-Au(2)S nanoparticles

Near infrared (NIR) absorbing Au-Au(2)S nanoparticles were modified with surfactants of different hydrocarbon chain lengths to allow loading of anticancer drug, cisplatin. The interfacial interactions and surfactant chain length effects on drug loading, optical properties and cytotoxicity were discussed in this work. Short-chain surfactants were oriented closer to the surface normal and were adsorbed at higher densities. Surface modification also changed the optical properties of the particles. Notably, particles modified with short-chain surfactants exhibited a red shift, whereas particles modified with long-chain surfactants showed a blue shift. The in vitro cytotoxicity of drug-loaded surface-modified particles was dependent on the surfactants' chain length. Significant cytotoxicity was observed for 1 mg/ml of drug-loaded particles using surfactants with the shortest chain length. After NIR triggered drug release, the released Pt compounds were observed to be cytotoxic, while remaining nanoparticles did not exhibit any cytotoxicity. Also, the released Pt compounds upon NIR irradiation of drug-loaded particles were observed to be more toxic and had a different molecular structure from cisplatin.

Near infrared-emitting Er- and Yb-Er- doped CeF3 nanoparticles with no visible upconversion

In this work, a host which interacts and enhanced energy transfer to the luminescent center such that it facilitates the infrared emission while avoiding undesired emissions was found. An intense emission at approximately 1530 nm with no other visible emissions was observed in Er- and Yb-Er- doped CeF3 nanoparticles upon excitation at approximately 975 nm. The average measured luminescence lifetimes of the approximately 1530 nm emission for heat-treated CeF3:Er and CeF3:Yb,Er nanoparticles was approximately 4.5-6.5 ms, with internal quantum efficiencies up to approximately 52-75%. These nanoparticles offer a vast range of potential applications, which include optical amplifiers, waveguides, laser materials and infrared imaging probes.

Evolution of photoluminescence mechanisms of Si(+)-implanted SiO2 films with thermal annealing

The information of band structure of silicon nanocrystal (nc-Si) embedded in SiO2 thin films synthesized by Si ion implantation and subsequent thermal annealing at various temperatures has been obtained from spectroscopy ellipsometric (SE) analysis. The indirect band structure and the energy gap of the nc-Si are not affected by the annealing. In contrast, the photoluminescence (PL) spectra show a continuous evolution with the annealing. Six PL bands located at 415, 460, 520, 630, 760, and 845 nm, respectively, have been observed depending on the annealing temperature. The annealing at 1100 degrees C yields the strongest PL band at 760 nm (approximately 1.63 eV) with the intensity much higher than that of all the other PL bands. Based on the knowledge of the band structure, the 760 nm-PL band could be attributed to the indirect band-to-band transition of the nc-Si assisted by the Si-O vibration of the nc-Si/SiO2 interface with the stretching frequency of approximately 1083 cm(-1) (approximately 0.13 eV). On the other hand, the first four PL bands mentioned above could originate from different extended defects in the oxide matrix, while the 845-nm PL band could be related to the interface luminescent centers.

A detailed understanding of the enhanced hypothermic productivity of interferon-gamma by Chinese-hamster ovary cells

Culturing CHO (Chinese-hamster ovary) cells at low temperature leads to growth arrest in the G0/G1 phase of the cell cycle and, in many cases, causes an increase in the specific productivity of recombinant protein. Controlled proliferation is often used to increase CHO specific productivity, and thus there is speculation that the enhanced productivity at low temperature is due to G0/G1-phase growth arrest. However, we show that the positive effect of low temperature on recombinant protein production is due to elevated mRNA levels and not due to growth arrest and that a cell line can still exhibit growth-associated productivity at low temperatures. Using a CHO cell producing recombinant human IFN-gamma (interferon-gamma), we show that productivity increases as the percentage of cells in the S phase of the cell cycle increases, at both 32 and 37 degrees C. The increased productivity is due to higher recombinant IFN-gamma mRNA levels. We also show that, for a given cell-cycle distribution, specific productivity increases as the temperature is lowered from 37 to 32 degrees C. Thus specific productivity is maximized when cells are actively growing (high percentage of S-phase cells) and also exposed to low temperature. These findings have important implications for cell-culture optimization and cell-line engineering, providing evidence that a CHO cell line capable of actively growing at low temperature would provide improved total protein production relative to the current growth strategies, namely 37 degrees C active growth or low-temperature growth arrest.

Predicting significant hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns

INTRODUCTION

This study aims to assess the usefulness of day 3 (49 to 72 hours) pre-phototherapy total serum bilirubin (TSB) in predicting subsequent significant hyperbilirubinaemia (SHB) and the feasibility of early discharge for term and near-term glucose-6-phosphate dehydrogenase (G6PD) deficient newborns.

MATERIALS AND METHODS

This prospective cohort study involved in born G6PD deficient neonates who were > or = 35 weeks and weighted > or = 2000 g at birth. TSB levels and phototherapy requirements in their first two weeks of life were studied. Day 3 pre-phototherapy TSB in the subgroup weighing > or = 2500 g at birth was analysed for its value in predicting subsequent SHB.

RESULTS

Of the 129 neonates, 58 (45%) required phototherapy in the first week. Of these, only 4 patients (3.1%) needed phototherapy to be restarted in the second week. Seventy-one (55%) neonates did not require phototherapy at all. In the absence of SHB in the first week, the probability of its development in the second week was zero (95% confidence interval, 0 to 0.057). In the subgroup weighing > or = 2500 g at birth, day 3 pre-phototherapy TSB < or = 154 umol/L predicted no measurable risk of subsequent SHB (sensitivity, 100%; 95% confidence interval, 91.4% to 100%; negative predictive value, 100%; 95% confidence interval, 86.7% to 100%).

CONCLUSIONS

G6PD deficient newborns without SHB in their first week of life were at no measurable risk of its development in the second week. Day 3 pre-phototherapy TSB in the subgroup weighing > or = 2500 g was useful for predicting the risk of subsequent SHB. Low-risk infants, thus identified, may be eligible for discharge on or before day 7 of life. Evidence-based early discharge can decrease the social and financial burden of G6PD deficiency in Singapore.

To establish the normal bone mineral density reference database for the Singapore male

INTRODUCTION

The objective of this study was to establish the normal bone mineral density (BMD) reference curve for the Asian Singapore male.

MATERIALS AND METHODS

Three hundred and eighty-three male subjects were enrolled; comprising of 309 Chinese, 44 Malays and 30 Indians resident in Singapore. Bone mineral density was measured at the lumbar spine and left hip using a Hologic QDR 4500 Elite dual-energy X-ray absorptiometry (DXA) scanner.

RESULTS

The mean peak BMD for the average lumbar spine and the neck of femur was 1.006 g/cm2 and 0.97 g/cm2, respectively. The mean peak BMD was taken at the 20 to 24 years age group at both the hip and spine based on data distribution for the various age groups. The BMD corresponding to -2.5 standard deviations from the peak adult value was 0.719 g/cm2 for the average lumbar spine and 0.655 g/cm2 for the neck of femur.

CONCLUSION

This Asian male BMD reference database, which is 10% and 5% lower than corresponding values from the Caucasian reference database, allows for more accurate diagnosis of osteoporosis in Asian males.

Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of HLA class II molecules

Langerhans cells (LC) represent the dendritic cell (DC) lineage in the epidermis. They capture and process antigens in the skin and subsequently migrate to the draining lymph nodes to activate naive T cells. Efficient uptake and processing of protein antigens by LC would, therefore, seem a prerequisite. We have now compared the capacity of human epidermal LC, blood-derived DC and peripheral blood mononuclear cells to endocytose and present (mannosylated) antigens to antigen-specific T cells. Moreover, we have determined the expression of mannose receptors, and the composition of the intracellular endosomal/lysosomal MHC class II-positive compartment. The results indicate that LC have poor endocytic capacity and do not exploit mannose receptor-mediated endocytosis pathways. Furthermore, the composition of the class II compartment in LC is distinct from that in other antigen-presenting cells and is characterized by the presence of relatively low levels of lysosomal markers. These results underscore the unique properties of LC and indicate that LC are relatively inefficient in antigen uptake, processing and presentation. This may serve to avoid hyper-responsiveness to harmless protein antigens that are likely to be frequently encountered in the skin due to (mechanical) skin damage.

Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells

Dendritic cells (DC) efficiently take up antigens by macropinocytosis and mannose receptor-mediated endocytosis. Here we show that endocytosis of mannose receptor-antigen complexes takes place via small coated vesicles, while non-mannosylated antigens were mainly present in larger vesicles. Shortly after internalization the mannose receptor and its ligand appeared in the larger vesicles. Within 10 min, the mannosylated and non-mannosylated antigens co-localized with typical markers for major histocompatibility complex class II-enriched compartments and lysosomes. In contrast, the mannose receptor appeared not to reach these compartments, suggesting that it releases its ligand in an earlier endosomal structure. Moreover, we demonstrate that mannosylation of protein antigen and peptides resulted in a 200-10,000-fold enhanced potency to stimulate HLA class II-restricted peptide-specific T cell clones compared to non-mannosylated peptides. Our results indicate that mannosylation of antigen leads to selective targeting and subsequent superior presentation by DC which may be applicable in vaccine design.

Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells

Dendritic cells (DCs) use macropinocytosis and mannose receptor mediated endocytosis for the uptake of exogenous antigens. Here we show that the endocytosis of the mannose receptor and mannosylated antigen is distinct from that of a non-mannosylated antigen. Shortly after internalization, however, both mannosylated and non-mannosylated antigen are found in an MIIC like compartment. The mannose receptor itself does not reach this compartment, and probably releases its ligand in an earlier endosomal structure. Finally, we found that mannosylation of peptides strongly enhanced their potency to stimulate HLA class II-restricted peptide-specific T cell clones. Our results indicate that mannosylation of antigen leads to selective targeting and subsequent superior presentation by DCs which may be useful for vaccine design.

Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94

Heat shock protein gp96 primes class I restricted cytotoxic T cells against antigens present in the cells from which it was isolated. Moreover, gp96 derived from certain tumors functions as an effective vaccine, causing complete tumor regressions in in vivo tumor challenge protocols. Because tumor-derived gp96 did not differ from gp96 isolated from normal tissues, a role for gp96 as a peptide carrier has been proposed. To test this hypothesis, we analyzed whether such an association of antigenic peptides with gp96 occurs in a well-defined viral model system. Here we present the full characterization of an antigenic peptide that endogenously associates with the stress protein gp96 in cells infected with vesicular stomatitis virus (VSV). This peptide is identical to the immunodominant peptide of VSV, which is also naturally presented by H-2Kb major histocompatibility complex class I molecules. This peptide associates with gp96 in VSV-infected cells regardless of the major histocompatibility com- plex haplotype of the cell. Our observations provide a biochemical basis for the vaccine function of gp96.